Twist incorporates Molcure AI into antibody discovery efforts

By The Science Advisory Board staff writers

July 26, 2021 -- Twist Bioscience announced that it has used Molcure's artificial intelligence (AI) technology to generate new cancer antibodies.

Molcure's AI platform is based on evolutionary molecular engineering, next-generation sequencing, and laboratory automation technologies. Together, the companies generated potent, binding antibodies to an undisclosed oncology target for Twist's internal pipeline of antibody candidates.

Twist and Molcure attribute the success in part to a technology agreement between the two firms under which they are working to develop new antibody targets, they said.

Twist acquires iGenomX for $35M
Twist Bioscience has acquired next-generation sequencing library preparation developer iGenomX for $35 million. The deal gives Twist a leg up in...
Twist, Regeneron partner on genetics NGS panel
Twist Bioscience is collaborating with Regeneron subsidiary Regeneron Genetics Center to launch a custom next-generation sequencing (NGS) population genetics...
Twist launches enzymatic fragmentation library prep kit
Twist Bioscience has unveiled its Twist Library Preparation Enzymatic Fragmentation Kit 2.0, an all-in-one solution designed to maximize accuracy and...
Twist announces Q2 financial results
Twist Bioscience announced that revenues grew in the company's second quarter of fiscal 2021, although the firm's net loss also grew.
Twist, Vivlion to generate gRNA libraries for CRISPR applications
Twist Bioscience and Vivlion are collaborating to generate guide RNA (gRNA) libraries for CRISPR genome engineering applications and target discovery...

Copyright © 2021 scienceboard.net


Conferences
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter